Skip to main content

#158381

Transient receptor potential ankyrin 1 (TRPA1)-GFP HeLa cell line

Cat. #158381

Transient receptor potential ankyrin 1 (TRPA1)-GFP HeLa cell line

Cat. #: 158381

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Peter Bradding ; Harvinder Virk

Institute: University of Leicester

Tool Details
Target Details
Handling
Related Tools

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Transient receptor potential ankyrin 1 (TRPA1)-GFP HeLa cell line
  • Research fields: Neurobiology
  • Parental cell: HeLa
  • Conditional: No
  • Description: The transient receptor potential cation channel family member ankyrin 1 (TRPA1) is an ion channel with high Ca2+ permeability that is activated by numerous noxious stimuli and by multiple products of oxidative stress. TRPA1 is a drug target with antagonists in phase I and II clinical trials. It is considered a potential target in multiple pain conditions including neuropathic, inflammatory and migraine pain, in addition to cough sensitivity, airway inflammation and fibrosisThis HeLa cell line is stably transfected with a dual-gene promotor (pCDH-CMV-MCS-EF1-copGFP) to express both GFP and hTRPA1.Forward TRPA1 Xba1 gggtctagaATGAAGCGCAGCCTGAGGAAG Reverse TRPA1 NotI ggggcggccgcttaAGGCTCAAGATGGTGTGTTTTTGCC

Target Details

  • Target: human Transient receptor potential cation channel family member ankyrin 1 (hTRPA1)

Handling

  • Format: Frozen
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: Transient receptor potential cation channel superfamily M member 2 (TRPM2)-GFP HeLa cell line ; HeLa pCDH-CMV-MCS-EF1-copGFP Control Cell Line

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.